Abstract
In their editorial, Garattini and Ghislandi (GG) suggest we should not necessarily worry about non-launches and launch delays of new chemical entities (NCEs) that could be attributed to price controls [1]. GG direct their com ments at Danzon et al. [2]. Garattini and Ghislandi use two main arguments. The first is a textbook welfare economics argument. If decisions to reimburse NCEs are based on maximization of a social
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call